跳至主要内容
临床试验/NCT02250716
NCT02250716Unknown不适用

A Comparison of Immediate Treatment of CIN1 With Cryotherapy and Regular 12 Month Cytology Follow up in HIV Seropositive Women

University of Witwatersrand, South Africa1 个研究点 分布在 1 个国家目标入组 480 人开始时间: 2012年10月1日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
480
试验地点
1
主要终点
Regresson of CIN1 to a normal biopsy

研究概览

简要总结

Based on the high incidence of cervical cancer and high grade dysplasia and increased progression and incomplete treatment of CIN2 and 3 in South Africa, we propose to study the effect of cryotherapy among HIV-positive women diagnosed with CIN 1 versus regular 12 month cytology follow-up. This study will be a dual-arm, open-label, randomized clinical trial for HIV-infected women diagnosed with CIN 1 and receiving care at the Themba Lethu Clinic, Helen Joseph Hospital, Johannesburg, South Africa. CIN 1 will be identified from patients who have had a colposcopic biopsy for persistent LSIL as per standard of care.

详细描述

Women with HIV have a higher risk of cervical cancer. Screening and treatment formaly of the disease is limited die to poor access of screening programs and multiple visits. Women with HIV also have high progressions rates of disease amd my need to be treated earliers. Cryotherapy is a low option and very easy to implement especially in low resource provinces.

  • It is cheaper and easier to administer than Large Loop electrosurgical excision procedure (LLETZ)
  • No histology or transportation costs of specimens
  • Less invasive than LLETZ
  • It is nurse driven and easily learned
  • It decreases loss to follow-up of patients due to reduced waiting time, transportation costs, time off work and HIV stigma

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • HIV -infected women whose biopsy proves CIN1 and who consent to study participants and procedures
  • CIN1 with no visible lesion
  • The entire ectocervical lesion should cover less than 75% of the cervix and not more than 2 - 3mm into the endocervical canal

排除标准

  • Pregnant women
  • Known and previous treatment for HSIL by any method (Cryotherapy, LEEP or cone biopsy)
  • Women who are menstruating or who have active pelvic inflammatory disease will be deferred from the study until the infection is cleared or the menstrual cycle has ended; the patient may then participate in the study.
  • Unsatisfactory colposcopic examination defined as inability to see the extent of the lesion in the endocervical canal and lesions deemed ineligible for cryotherapy by an OB/GYN specialist.
  • Previous hysterectomy with removal of the cervix

结局指标

主要结局

Regresson of CIN1 to a normal biopsy

时间窗: 12 month

Treatment failure is the progression of CIN1 to CIN2

次要结局

未报告次要终点

研究者

发起方
University of Witwatersrand, South Africa
申办方类型
Other
责任方
Principal Investigator
主要研究者

Cynthia S Firnhaber

Associate Professor of Medicine

University of Witwatersrand, South Africa

研究点 (1)

Loading locations...

相似试验

A Comparison of Immediate Treatment of CIN1 With... | 临床试验